nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—SLC22A6—Captopril—systemic scleroderma	0.426	0.76	CbGbCtD
Nalidixic Acid—SLC22A6—Methotrexate—systemic scleroderma	0.135	0.24	CbGbCtD
Nalidixic Acid—Blister—Captopril—systemic scleroderma	0.00717	0.0163	CcSEcCtD
Nalidixic Acid—Papilloedema—Prednisone—systemic scleroderma	0.00684	0.0156	CcSEcCtD
Nalidixic Acid—Cholestasis—Captopril—systemic scleroderma	0.0068	0.0155	CcSEcCtD
Nalidixic Acid—Cholestasis—Azathioprine—systemic scleroderma	0.00594	0.0135	CcSEcCtD
Nalidixic Acid—Epilepsy—Prednisone—systemic scleroderma	0.00572	0.013	CcSEcCtD
Nalidixic Acid—Swelling—Pentoxifylline—systemic scleroderma	0.00561	0.0128	CcSEcCtD
Nalidixic Acid—Cholestasis—Leflunomide—systemic scleroderma	0.00561	0.0128	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisone—systemic scleroderma	0.0052	0.0119	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.00511	0.0117	CcSEcCtD
Nalidixic Acid—Injury—Mometasone—systemic scleroderma	0.00465	0.0106	CcSEcCtD
Nalidixic Acid—Trauma—Prednisone—systemic scleroderma	0.00457	0.0104	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Captopril—systemic scleroderma	0.00416	0.00947	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Captopril—systemic scleroderma	0.00392	0.00894	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00388	0.00883	CcSEcCtD
Nalidixic Acid—Drowsiness—Pentoxifylline—systemic scleroderma	0.00381	0.00869	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisone—systemic scleroderma	0.00353	0.00805	CcSEcCtD
Nalidixic Acid—Swelling—Mycophenolic acid—systemic scleroderma	0.00334	0.00762	CcSEcCtD
Nalidixic Acid—Eosinophilia—Captopril—systemic scleroderma	0.00321	0.00731	CcSEcCtD
Nalidixic Acid—Injury—Mycophenolic acid—systemic scleroderma	0.00321	0.00731	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00319	0.00728	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.00309	0.00703	CcSEcCtD
Nalidixic Acid—Erythema—Pentoxifylline—systemic scleroderma	0.00298	0.00679	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Captopril—systemic scleroderma	0.00296	0.00674	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00294	0.0067	CcSEcCtD
Nalidixic Acid—Injury—Lisinopril—systemic scleroderma	0.00289	0.00658	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00288	0.00656	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00287	0.00653	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00274	0.00625	CcSEcCtD
Nalidixic Acid—Angioedema—Pentoxifylline—systemic scleroderma	0.00272	0.00621	CcSEcCtD
Nalidixic Acid—Leukopenia—Pentoxifylline—systemic scleroderma	0.00267	0.00608	CcSEcCtD
Nalidixic Acid—Diplopia—Lisinopril—systemic scleroderma	0.00266	0.00605	CcSEcCtD
Nalidixic Acid—Eosinophilia—Leflunomide—systemic scleroderma	0.00265	0.00603	CcSEcCtD
Nalidixic Acid—Convulsion—Pentoxifylline—systemic scleroderma	0.00258	0.00588	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00587	CcSEcCtD
Nalidixic Acid—Injury—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00577	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.0025	0.0057	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Captopril—systemic scleroderma	0.00245	0.00559	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00555	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00243	0.00554	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00238	0.00543	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00236	0.00538	CcSEcCtD
Nalidixic Acid—Angioedema—Mometasone—systemic scleroderma	0.00235	0.00535	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00234	0.00532	CcSEcCtD
Nalidixic Acid—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00233	0.0053	CcSEcCtD
Nalidixic Acid—Eosinophilia—Lisinopril—systemic scleroderma	0.00227	0.00518	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00518	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00223	0.00508	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00222	0.00505	CcSEcCtD
Nalidixic Acid—Arthralgia—Mometasone—systemic scleroderma	0.00219	0.00499	CcSEcCtD
Nalidixic Acid—Somnolence—Pentoxifylline—systemic scleroderma	0.00216	0.00493	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Azathioprine—systemic scleroderma	0.00214	0.00488	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Mometasone—systemic scleroderma	0.0021	0.00478	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.0021	0.00477	CcSEcCtD
Nalidixic Acid—Angioedema—Captopril—systemic scleroderma	0.00206	0.0047	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00203	0.00462	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Leflunomide—systemic scleroderma	0.00202	0.00461	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00201	0.00457	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00199	0.00453	CcSEcCtD
Nalidixic Acid—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00197	0.00448	CcSEcCtD
Nalidixic Acid—Urticaria—Pentoxifylline—systemic scleroderma	0.00193	0.0044	CcSEcCtD
Nalidixic Acid—Arthralgia—Captopril—systemic scleroderma	0.00192	0.00438	CcSEcCtD
Nalidixic Acid—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00192	0.00438	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00191	0.00436	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mometasone—systemic scleroderma	0.00188	0.00429	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Captopril—systemic scleroderma	0.00184	0.0042	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Captopril—systemic scleroderma	0.00181	0.00411	CcSEcCtD
Nalidixic Acid—Leukopenia—Azathioprine—systemic scleroderma	0.00176	0.00402	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00401	CcSEcCtD
Nalidixic Acid—Asthenia—Pentoxifylline—systemic scleroderma	0.00175	0.00398	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Lisinopril—systemic scleroderma	0.00174	0.00396	CcSEcCtD
Nalidixic Acid—Pruritus—Pentoxifylline—systemic scleroderma	0.00172	0.00392	CcSEcCtD
Nalidixic Acid—Injury—Prednisone—systemic scleroderma	0.00172	0.00391	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00172	0.00391	CcSEcCtD
Nalidixic Acid—Angioedema—Leflunomide—systemic scleroderma	0.0017	0.00388	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00168	0.00383	CcSEcCtD
Nalidixic Acid—Arthralgia—Azathioprine—systemic scleroderma	0.00168	0.00382	CcSEcCtD
Nalidixic Acid—Vertigo—Leflunomide—systemic scleroderma	0.00167	0.00381	CcSEcCtD
Nalidixic Acid—Leukopenia—Leflunomide—systemic scleroderma	0.00167	0.0038	CcSEcCtD
Nalidixic Acid—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00166	0.00379	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mometasone—systemic scleroderma	0.00166	0.00378	CcSEcCtD
Nalidixic Acid—Paraesthesia—Captopril—systemic scleroderma	0.00166	0.00377	CcSEcCtD
Nalidixic Acid—Somnolence—Captopril—systemic scleroderma	0.00164	0.00373	CcSEcCtD
Nalidixic Acid—Dizziness—Pentoxifylline—systemic scleroderma	0.00161	0.00367	CcSEcCtD
Nalidixic Acid—Erythema—Lisinopril—systemic scleroderma	0.0016	0.00364	CcSEcCtD
Nalidixic Acid—Vertigo—Mycophenolic acid—systemic scleroderma	0.0016	0.00364	CcSEcCtD
Nalidixic Acid—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00159	0.00362	CcSEcCtD
Nalidixic Acid—Arthralgia—Leflunomide—systemic scleroderma	0.00159	0.00361	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00158	0.00359	CcSEcCtD
Nalidixic Acid—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00354	CcSEcCtD
Nalidixic Acid—Vomiting—Pentoxifylline—systemic scleroderma	0.00155	0.00352	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Prednisone—systemic scleroderma	0.00154	0.00351	CcSEcCtD
Nalidixic Acid—Convulsion—Mycophenolic acid—systemic scleroderma	0.00154	0.00351	CcSEcCtD
Nalidixic Acid—Rash—Pentoxifylline—systemic scleroderma	0.00153	0.00349	CcSEcCtD
Nalidixic Acid—Dermatitis—Pentoxifylline—systemic scleroderma	0.00153	0.00349	CcSEcCtD
Nalidixic Acid—Headache—Pentoxifylline—systemic scleroderma	0.00152	0.00347	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00152	0.00346	CcSEcCtD
Nalidixic Acid—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00151	0.00345	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Captopril—systemic scleroderma	0.00151	0.00343	CcSEcCtD
Nalidixic Acid—Asthenia—Mometasone—systemic scleroderma	0.00151	0.00343	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00149	0.00339	CcSEcCtD
Nalidixic Acid—Pruritus—Mometasone—systemic scleroderma	0.00149	0.00338	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00147	0.00334	CcSEcCtD
Nalidixic Acid—Angioedema—Lisinopril—systemic scleroderma	0.00146	0.00333	CcSEcCtD
Nalidixic Acid—Abdominal pain—Captopril—systemic scleroderma	0.00146	0.00332	CcSEcCtD
Nalidixic Acid—Nausea—Pentoxifylline—systemic scleroderma	0.00145	0.00329	CcSEcCtD
Nalidixic Acid—Vertigo—Lisinopril—systemic scleroderma	0.00144	0.00327	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mometasone—systemic scleroderma	0.00144	0.00327	CcSEcCtD
Nalidixic Acid—Leukopenia—Lisinopril—systemic scleroderma	0.00143	0.00326	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00142	0.00323	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00138	0.00315	CcSEcCtD
Nalidixic Acid—Paraesthesia—Leflunomide—systemic scleroderma	0.00136	0.00311	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00136	0.0031	CcSEcCtD
Nalidixic Acid—Arthralgia—Lisinopril—systemic scleroderma	0.00136	0.0031	CcSEcCtD
Nalidixic Acid—Vomiting—Mometasone—systemic scleroderma	0.00133	0.00304	CcSEcCtD
Nalidixic Acid—Rash—Mometasone—systemic scleroderma	0.00132	0.00302	CcSEcCtD
Nalidixic Acid—Asthenia—Captopril—systemic scleroderma	0.00132	0.00301	CcSEcCtD
Nalidixic Acid—Dermatitis—Mometasone—systemic scleroderma	0.00132	0.00301	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00132	0.00301	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00132	0.003	CcSEcCtD
Nalidixic Acid—Headache—Mometasone—systemic scleroderma	0.00132	0.003	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00131	0.00297	CcSEcCtD
Nalidixic Acid—Pruritus—Captopril—systemic scleroderma	0.0013	0.00297	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.0013	0.00297	CcSEcCtD
Nalidixic Acid—Somnolence—Mycophenolic acid—systemic scleroderma	0.00129	0.00294	CcSEcCtD
Nalidixic Acid—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00292	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00128	0.00291	CcSEcCtD
Nalidixic Acid—Abdominal pain—Azathioprine—systemic scleroderma	0.00127	0.0029	CcSEcCtD
Nalidixic Acid—Diarrhoea—Captopril—systemic scleroderma	0.00126	0.00287	CcSEcCtD
Nalidixic Acid—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00287	CcSEcCtD
Nalidixic Acid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00286	CcSEcCtD
Nalidixic Acid—Nausea—Mometasone—systemic scleroderma	0.00125	0.00284	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00124	0.00283	CcSEcCtD
Nalidixic Acid—Dizziness—Captopril—systemic scleroderma	0.00122	0.00278	CcSEcCtD
Nalidixic Acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00277	CcSEcCtD
Nalidixic Acid—Urticaria—Leflunomide—systemic scleroderma	0.00121	0.00275	CcSEcCtD
Nalidixic Acid—Abdominal pain—Leflunomide—systemic scleroderma	0.0012	0.00274	CcSEcCtD
Nalidixic Acid—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00272	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00119	0.00272	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00119	0.00271	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00119	0.0027	CcSEcCtD
Nalidixic Acid—Paraesthesia—Lisinopril—systemic scleroderma	0.00117	0.00267	CcSEcCtD
Nalidixic Acid—Vomiting—Captopril—systemic scleroderma	0.00117	0.00267	CcSEcCtD
Nalidixic Acid—Rash—Captopril—systemic scleroderma	0.00116	0.00265	CcSEcCtD
Nalidixic Acid—Dermatitis—Captopril—systemic scleroderma	0.00116	0.00265	CcSEcCtD
Nalidixic Acid—Somnolence—Lisinopril—systemic scleroderma	0.00116	0.00264	CcSEcCtD
Nalidixic Acid—Headache—Captopril—systemic scleroderma	0.00116	0.00263	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00115	0.00261	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00261	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—systemic scleroderma	0.00113	0.00257	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00255	CcSEcCtD
Nalidixic Acid—Diarrhoea—Azathioprine—systemic scleroderma	0.0011	0.00251	CcSEcCtD
Nalidixic Acid—Nausea—Captopril—systemic scleroderma	0.0011	0.0025	CcSEcCtD
Nalidixic Acid—Asthenia—Leflunomide—systemic scleroderma	0.00109	0.00248	CcSEcCtD
Nalidixic Acid—Pruritus—Leflunomide—systemic scleroderma	0.00108	0.00245	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00107	0.00243	CcSEcCtD
Nalidixic Acid—Dizziness—Azathioprine—systemic scleroderma	0.00106	0.00242	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00237	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00104	0.00237	CcSEcCtD
Nalidixic Acid—Asthenia—Mycophenolic acid—systemic scleroderma	0.00104	0.00237	CcSEcCtD
Nalidixic Acid—Diarrhoea—Leflunomide—systemic scleroderma	0.00104	0.00237	CcSEcCtD
Nalidixic Acid—Urticaria—Lisinopril—systemic scleroderma	0.00104	0.00236	CcSEcCtD
Nalidixic Acid—Abdominal pain—Lisinopril—systemic scleroderma	0.00103	0.00235	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00234	CcSEcCtD
Nalidixic Acid—Pruritus—Mycophenolic acid—systemic scleroderma	0.00103	0.00234	CcSEcCtD
Nalidixic Acid—Vomiting—Azathioprine—systemic scleroderma	0.00102	0.00233	CcSEcCtD
Nalidixic Acid—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00232	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—systemic scleroderma	0.00102	0.00232	CcSEcCtD
Nalidixic Acid—Rash—Azathioprine—systemic scleroderma	0.00101	0.00231	CcSEcCtD
Nalidixic Acid—Dermatitis—Azathioprine—systemic scleroderma	0.00101	0.00231	CcSEcCtD
Nalidixic Acid—Headache—Azathioprine—systemic scleroderma	0.00101	0.0023	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00101	0.0023	CcSEcCtD
Nalidixic Acid—Dizziness—Leflunomide—systemic scleroderma	0.001	0.00229	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000992	0.00226	CcSEcCtD
Nalidixic Acid—Vomiting—Leflunomide—systemic scleroderma	0.000966	0.0022	CcSEcCtD
Nalidixic Acid—Dizziness—Mycophenolic acid—systemic scleroderma	0.000959	0.00218	CcSEcCtD
Nalidixic Acid—Rash—Leflunomide—systemic scleroderma	0.000958	0.00218	CcSEcCtD
Nalidixic Acid—Dermatitis—Leflunomide—systemic scleroderma	0.000957	0.00218	CcSEcCtD
Nalidixic Acid—Nausea—Azathioprine—systemic scleroderma	0.000956	0.00218	CcSEcCtD
Nalidixic Acid—Headache—Leflunomide—systemic scleroderma	0.000952	0.00217	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—systemic scleroderma	0.00095	0.00216	CcSEcCtD
Nalidixic Acid—Asthenia—Lisinopril—systemic scleroderma	0.000937	0.00213	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000935	0.00213	CcSEcCtD
Nalidixic Acid—Pruritus—Lisinopril—systemic scleroderma	0.000924	0.0021	CcSEcCtD
Nalidixic Acid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000922	0.0021	CcSEcCtD
Nalidixic Acid—Rash—Mycophenolic acid—systemic scleroderma	0.000914	0.00208	CcSEcCtD
Nalidixic Acid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000913	0.00208	CcSEcCtD
Nalidixic Acid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000909	0.00207	CcSEcCtD
Nalidixic Acid—Headache—Mycophenolic acid—systemic scleroderma	0.000908	0.00207	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00206	CcSEcCtD
Nalidixic Acid—Nausea—Leflunomide—systemic scleroderma	0.000903	0.00206	CcSEcCtD
Nalidixic Acid—Diarrhoea—Lisinopril—systemic scleroderma	0.000893	0.00204	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—systemic scleroderma	0.000879	0.002	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—systemic scleroderma	0.000868	0.00198	CcSEcCtD
Nalidixic Acid—Dizziness—Lisinopril—systemic scleroderma	0.000863	0.00197	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—systemic scleroderma	0.000862	0.00197	CcSEcCtD
Nalidixic Acid—Nausea—Mycophenolic acid—systemic scleroderma	0.000861	0.00196	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—systemic scleroderma	0.000854	0.00194	CcSEcCtD
Nalidixic Acid—Vomiting—Lisinopril—systemic scleroderma	0.00083	0.00189	CcSEcCtD
Nalidixic Acid—Rash—Lisinopril—systemic scleroderma	0.000823	0.00188	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—systemic scleroderma	0.000823	0.00188	CcSEcCtD
Nalidixic Acid—Dermatitis—Lisinopril—systemic scleroderma	0.000822	0.00187	CcSEcCtD
Nalidixic Acid—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000821	0.00187	CcSEcCtD
Nalidixic Acid—Headache—Lisinopril—systemic scleroderma	0.000818	0.00186	CcSEcCtD
Nalidixic Acid—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000809	0.00184	CcSEcCtD
Nalidixic Acid—Arthralgia—Prednisone—systemic scleroderma	0.000809	0.00184	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—systemic scleroderma	0.000794	0.00181	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000783	0.00178	CcSEcCtD
Nalidixic Acid—Nausea—Lisinopril—systemic scleroderma	0.000776	0.00177	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—systemic scleroderma	0.000775	0.00177	CcSEcCtD
Nalidixic Acid—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000757	0.00172	CcSEcCtD
Nalidixic Acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000727	0.00166	CcSEcCtD
Nalidixic Acid—Rash—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00164	CcSEcCtD
Nalidixic Acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00164	CcSEcCtD
Nalidixic Acid—Headache—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00163	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—systemic scleroderma	0.000713	0.00163	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—systemic scleroderma	0.000711	0.00162	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000707	0.00161	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—systemic scleroderma	0.000696	0.00159	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—systemic scleroderma	0.000688	0.00157	CcSEcCtD
Nalidixic Acid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00068	0.00155	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—systemic scleroderma	0.000676	0.00154	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000648	0.00148	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000635	0.00145	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000634	0.00144	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisone—systemic scleroderma	0.000616	0.0014	CcSEcCtD
Nalidixic Acid—Abdominal pain—Prednisone—systemic scleroderma	0.000613	0.0014	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00059	0.00135	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—systemic scleroderma	0.000582	0.00133	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—systemic scleroderma	0.000576	0.00131	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—systemic scleroderma	0.000556	0.00127	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—systemic scleroderma	0.000549	0.00125	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—systemic scleroderma	0.000531	0.00121	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00053	0.00121	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—systemic scleroderma	0.000515	0.00117	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisone—systemic scleroderma	0.000513	0.00117	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—systemic scleroderma	0.000512	0.00117	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—systemic scleroderma	0.000493	0.00112	CcSEcCtD
Nalidixic Acid—Rash—Prednisone—systemic scleroderma	0.000489	0.00111	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—systemic scleroderma	0.000488	0.00111	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—systemic scleroderma	0.000486	0.00111	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—systemic scleroderma	0.000465	0.00106	CcSEcCtD
Nalidixic Acid—Nausea—Prednisone—systemic scleroderma	0.000461	0.00105	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—systemic scleroderma	0.000459	0.00104	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—systemic scleroderma	0.000443	0.00101	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—systemic scleroderma	0.000429	0.000976	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—systemic scleroderma	0.000412	0.000939	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—systemic scleroderma	0.000409	0.000931	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—systemic scleroderma	0.000408	0.00093	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—systemic scleroderma	0.000406	0.000925	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—systemic scleroderma	0.000385	0.000877	CcSEcCtD
